APO RESEARCH · REPORT
Monoclonal Mouse Antibody
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Product & engineering
Understand the product.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Selected research
Industry Growth & Trends
Global Monoclonal Mouse Antibody Industry Growth and Trends Forecast to 2032
Market perspective
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals and Seattle Genetics, etc, with about 57% market shares.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Monoclonal Mouse Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Monoclonal Mouse Antibody market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Monoclonal Mouse Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Monoclonal Mouse Antibody.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Monoclonal Mouse Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Monoclonal Mouse Antibody Market by Company
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Monoclonal Mouse Antibody Segment by Type
IgM
IgG
IgA
Others
Monoclonal Mouse Antibody Segment by Application
Therapeutic
Research
Diagnostic
ELISA kits
Monoclonal Mouse Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monoclonal Mouse Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monoclonal Mouse Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monoclonal Mouse Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Mouse Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Monoclonal Mouse Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- IgM
- IgG
- IgA
- Others
Applications
- Therapeutic
- Research
- Diagnostic
- ELISA kits
Companies covered
- Roche
- Johnson & Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Monoclonal Mouse Antibody Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Monoclonal Mouse Antibody Sales Estimates and Forecasts (2021-2032)
- 1.3 Monoclonal Mouse Antibody Market by Type
- 1.3.1 IgM
- 1.3.2 IgG
- 1.3.3 IgA
- 1.3.4 Others
- 1.4 Global Monoclonal Mouse Antibody Market Size by Type
- 1.4.1 Global Monoclonal Mouse Antibody Market Size Overview by Type (2021-2032)
- 1.4.2 Global Monoclonal Mouse Antibody Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Monoclonal Mouse Antibody Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Monoclonal Mouse Antibody Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Monoclonal Mouse Antibody Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Monoclonal Mouse Antibody Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Monoclonal Mouse Antibody Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Monoclonal Mouse Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Monoclonal Mouse Antibody Industry Trends
- 2.2 Monoclonal Mouse Antibody Industry Drivers
- 2.3 Monoclonal Mouse Antibody Industry Opportunities and Challenges
- 2.4 Monoclonal Mouse Antibody Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Monoclonal Mouse Antibody Revenue (2021-2026)
- 3.2 Global Top Players by Monoclonal Mouse Antibody Sales (2021-2026)
- 3.3 Global Top Players by Monoclonal Mouse Antibody Price (2021-2026)
- 3.4 Global Monoclonal Mouse Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Monoclonal Mouse Antibody Major Company Production Sites & Headquarters
- 3.6 Global Monoclonal Mouse Antibody Company, Product Type & Application
- 3.7 Global Monoclonal Mouse Antibody Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Monoclonal Mouse Antibody Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Monoclonal Mouse Antibody Players Market Share by Revenue in 2025
- 3.8.3 2025 Monoclonal Mouse Antibody Tier 1, Tier 2, and Tier 3
4 Monoclonal Mouse Antibody Regional Status and Outlook
- 4.1 Global Monoclonal Mouse Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Monoclonal Mouse Antibody Historic Market Size by Region
- 4.2.1 Global Monoclonal Mouse Antibody Sales in Volume by Region (2021-2026)
- 4.2.2 Global Monoclonal Mouse Antibody Sales in Value by Region (2021-2026)
- 4.2.3 Global Monoclonal Mouse Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Monoclonal Mouse Antibody Forecasted Market Size by Region
- 4.3.1 Global Monoclonal Mouse Antibody Sales in Volume by Region (2027-2032)
- 4.3.2 Global Monoclonal Mouse Antibody Sales in Value by Region (2027-2032)
- 4.3.3 Global Monoclonal Mouse Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Monoclonal Mouse Antibody by Application
- 5.1 Monoclonal Mouse Antibody Market by Application
- 5.1.1 Therapeutic
- 5.1.2 Research
- 5.1.3 Diagnostic
- 5.1.4 ELISA kits
- 5.2 Global Monoclonal Mouse Antibody Market Size by Application
- 5.2.1 Global Monoclonal Mouse Antibody Market Size Overview by Application (2021-2032)
- 5.2.2 Global Monoclonal Mouse Antibody Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Monoclonal Mouse Antibody Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Monoclonal Mouse Antibody Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Monoclonal Mouse Antibody Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Monoclonal Mouse Antibody Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Monoclonal Mouse Antibody Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Monoclonal Mouse Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Roche
- 6.1.1 Roche Company Information
- 6.1.2 Roche Business Overview
- 6.1.3 Roche Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Roche Monoclonal Mouse Antibody Product Portfolio
- 6.1.5 Roche Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck Monoclonal Mouse Antibody Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Novartis
- 6.4.1 Novartis Company Information
- 6.4.2 Novartis Business Overview
- 6.4.3 Novartis Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Novartis Monoclonal Mouse Antibody Product Portfolio
- 6.4.5 Novartis Recent Developments
- 6.5 AbbVie
- 6.5.1 AbbVie Company Information
- 6.5.2 AbbVie Business Overview
- 6.5.3 AbbVie Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 AbbVie Monoclonal Mouse Antibody Product Portfolio
- 6.5.5 AbbVie Recent Developments
- 6.6 Amgen
- 6.6.1 Amgen Company Information
- 6.6.2 Amgen Business Overview
- 6.6.3 Amgen Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Amgen Monoclonal Mouse Antibody Product Portfolio
- 6.6.5 Amgen Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Pfizer Monoclonal Mouse Antibody Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Bayer Monoclonal Mouse Antibody Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 Lilly
- 6.9.1 Lilly Company Information
- 6.9.2 Lilly Business Overview
- 6.9.3 Lilly Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Lilly Monoclonal Mouse Antibody Product Portfolio
- 6.9.5 Lilly Recent Developments
- 6.10 Bristol-Myers Squibb
- 6.10.1 Bristol-Myers Squibb Company Information
- 6.10.2 Bristol-Myers Squibb Business Overview
- 6.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio
- 6.10.5 Bristol-Myers Squibb Recent Developments
- 6.11 GlaxoSmithKline
- 6.11.1 GlaxoSmithKline Company Information
- 6.11.2 GlaxoSmithKline Business Overview
- 6.11.3 GlaxoSmithKline Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio
- 6.11.5 GlaxoSmithKline Recent Developments
- 6.12 Biogen
- 6.12.1 Biogen Company Information
- 6.12.2 Biogen Business Overview
- 6.12.3 Biogen Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Biogen Monoclonal Mouse Antibody Product Portfolio
- 6.12.5 Biogen Recent Developments
- 6.13 AstraZeneca
- 6.13.1 AstraZeneca Company Information
- 6.13.2 AstraZeneca Business Overview
- 6.13.3 AstraZeneca Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 AstraZeneca Monoclonal Mouse Antibody Product Portfolio
- 6.13.5 AstraZeneca Recent Developments
- 6.14 Sanofi
- 6.14.1 Sanofi Company Information
- 6.14.2 Sanofi Business Overview
- 6.14.3 Sanofi Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Sanofi Monoclonal Mouse Antibody Product Portfolio
- 6.14.5 Sanofi Recent Developments
- 6.15 Alexion Pharmaceuticals
- 6.15.1 Alexion Pharmaceuticals Company Information
- 6.15.2 Alexion Pharmaceuticals Business Overview
- 6.15.3 Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio
- 6.15.5 Alexion Pharmaceuticals Recent Developments
- 6.16 Seattle Genetics
- 6.16.1 Seattle Genetics Company Information
- 6.16.2 Seattle Genetics Business Overview
- 6.16.3 Seattle Genetics Monoclonal Mouse Antibody Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Seattle Genetics Monoclonal Mouse Antibody Product Portfolio
- 6.16.5 Seattle Genetics Recent Developments
7 North America by Country
- 7.1 North America Monoclonal Mouse Antibody Sales by Country
- 7.1.1 North America Monoclonal Mouse Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Monoclonal Mouse Antibody Sales by Country (2021-2026)
- 7.1.3 North America Monoclonal Mouse Antibody Sales Forecast by Country (2027-2032)
- 7.2 North America Monoclonal Mouse Antibody Market Size by Country
- 7.2.1 North America Monoclonal Mouse Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Monoclonal Mouse Antibody Market Size by Country (2021-2026)
- 7.2.3 North America Monoclonal Mouse Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Monoclonal Mouse Antibody Sales by Country
- 8.1.1 Europe Monoclonal Mouse Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Monoclonal Mouse Antibody Sales by Country (2021-2026)
- 8.1.3 Europe Monoclonal Mouse Antibody Sales Forecast by Country (2027-2032)
- 8.2 Europe Monoclonal Mouse Antibody Market Size by Country
- 8.2.1 Europe Monoclonal Mouse Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Monoclonal Mouse Antibody Market Size by Country (2021-2026)
- 8.2.3 Europe Monoclonal Mouse Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Monoclonal Mouse Antibody Sales by Country
- 9.1.1 Asia-Pacific Monoclonal Mouse Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Monoclonal Mouse Antibody Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Monoclonal Mouse Antibody Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Monoclonal Mouse Antibody Market Size by Country
- 9.2.1 Asia-Pacific Monoclonal Mouse Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Monoclonal Mouse Antibody Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Monoclonal Mouse Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Monoclonal Mouse Antibody Sales by Country
- 10.1.1 South America Monoclonal Mouse Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Monoclonal Mouse Antibody Sales by Country (2021-2026)
- 10.1.3 South America Monoclonal Mouse Antibody Sales Forecast by Country (2027-2032)
- 10.2 South America Monoclonal Mouse Antibody Market Size by Country
- 10.2.1 South America Monoclonal Mouse Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Monoclonal Mouse Antibody Market Size by Country (2021-2026)
- 10.2.3 South America Monoclonal Mouse Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Monoclonal Mouse Antibody Sales by Country
- 11.1.1 Middle East and Africa Monoclonal Mouse Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Monoclonal Mouse Antibody Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Monoclonal Mouse Antibody Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Monoclonal Mouse Antibody Market Size by Country
- 11.2.1 Middle East and Africa Monoclonal Mouse Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Monoclonal Mouse Antibody Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Monoclonal Mouse Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Monoclonal Mouse Antibody Value Chain Analysis
- 12.1.1 Monoclonal Mouse Antibody Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Monoclonal Mouse Antibody Production Mode & Process
- 12.2 Monoclonal Mouse Antibody Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Monoclonal Mouse Antibody Distributors
- 12.2.3 Monoclonal Mouse Antibody Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst